ProKidney Corp.
PROK
$1.33
-$0.08-5.34%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -33.63% | 0.44% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -33.63% | 0.44% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -33.63% | 0.44% | |||
| SG&A Expenses | 9.82% | -3.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.45% | -1.64% | |||
| Operating Income | -7.66% | 1.65% | |||
| Income Before Tax | -8.95% | -0.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -8.95% | -4.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -20.24% | 4.45% | |||
| Net Income | -41.85% | -4.19% | |||
| EBIT | -7.66% | 1.65% | |||
| EBITDA | -7.90% | 1.32% | |||
| EPS Basic | -7.86% | -3.52% | |||
| Normalized Basic EPS | -106.29% | 20.99% | |||
| EPS Diluted | -7.86% | -3.52% | |||
| Normalized Diluted EPS | -106.29% | 20.99% | |||
| Average Basic Shares Outstanding | 31.45% | 0.65% | |||
| Average Diluted Shares Outstanding | 31.45% | 0.65% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||